DelveInsight's "YUTIQ Market Size, Forecast, and Market Insight Report" highlights the details around YUTIQ, a sterile ...

YUTIQ addresses a significant unmet need in the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. The uveitis treatment market is projected to grow steadily ...

Generated $166.8 million in 1Q 2025 revenues, including $149.9 million in U.S. net product sales <li /> SYFOVRE® (pegcetacop ...

In clinical trials, use of SYFOVRE was associated with episodes of intraocular inflammation including: vitritis, vitreal cells, iridocyclitis, uveitis, anterior chamber cells, iritis, and anterior ...

iritis and iridocyclitis, diffuse posterior uveitis and choroiditis, optic neuritis, chorioretinitis, and anterior segment inflammation. “In a preclinical model of autoimmune uveitis, Cortrophin Gel ...

Ocular examination revealed episcleritis, scleritis, iritis, trabeculitis and papillitis in both ... Psoriatic uveitis was also considered; however, it typically causes a chronic anterior uveitis with ...

The anterior chamber is situated between the iris and the cornea, of which aqueous humour flows ... and Eleftherios Agorogiannis from the Uveitis Service, Manchester Royal Eye Hospital, Oxford Road, ...

In this Healio Video Perspective from the Retina World Congress, Dilraj S. Grewal, MD, FASRS, provides an update on the progress of therapies for noninfectious uveitis. While some therapies failed ...

Macular edema is the leading cause of visual loss in uveitic patients, and is a predictable feature of pars planitis, Behcet's and sarcoid uveitis, HLA-B27 related uveitis, and birdshot ...